TABLE OF CONTENTS
Volume 4, Issue 1 (October 2006)
Special Issue: Global Review of Generic Medicines
Papers |
US Case Reports |
EU Case Reports |
US Legal and Regulatory Update |
EU Legal and Regulatory Update |
Patent Expiry Impact Predictor
Editorial
Editorial FREE
Tommy Erdei
J Generic Med 4: 1-3; doi:10.1057/palgrave.jgm.4950049
Papers
The European generic pharmaceutical market in review: 2006 and beyond FREE
Greg Perry
J Generic Med 4: 4-14; doi:10.1057/palgrave.jgm.4950041
America's generic pharmaceutical industry: Opportunities and challenges in 2006 and beyond FREE
Kathleen Jaeger
J Generic Med 4: 15-22; doi:10.1057/palgrave.jgm.4950047
Japan's healthcare system and pharmaceutical industry FREE
Osamu Saigusa
J Generic Med 4: 23-29; doi:10.1057/palgrave.jgm.4950039
Generics in Latin America: An analysis of the Brazilian experience
Vera Valente
J Generic Med 4: 30-36; doi:10.1057/palgrave.jgm.4950045
India: A global strategic asset for developed world market businesses
Brian Tempest
J Generic Med 4: 37-42; doi:10.1057/palgrave.jgm.4950046
Potential savings from increased substitution of generic for originator medicines in Europe
Steven Simoens and Sandra De Coster
J Generic Med 4: 43-45; doi:10.1057/palgrave.jgm.4950040
US Case Reports
Mylan v FDA: Another court decision in favour of 'authorised generics'
Frederick H Rein and Amanda M Kessel
J Generic Med 4: 46-52; doi:10.1057/palgrave.jgm.4950043
EU Case Reports
Cross-border EU patent actions; UK Lipitor judgment upheld; developments in the EPO
Michael Burdon and Robert Stephen
J Generic Med 4: 53-58; doi:10.1057/palgrave.jgm.4950044
US Legal and Regulatory Update
A missed opportunity — LabCorp v Metabolite Laboratories
Sean Myers-Payne
J Generic Med 4: 59-63; doi:10.1057/palgrave.jgm.4950042
EU Legal and Regulatory Update
EU Legal and Regulatory Update
J Generic Med 4: 64-72; doi:10.1057/palgrave.jgm.4950050
